US Stock MarketDetailed Quotes

AYTU Aytu BioPharma

Watchlist
  • 2.9043
  • +0.0643+2.26%
Close Apr 26 16:00 ET
16.17MMarket Cap-724P/E (TTM)

Aytu BioPharma Key Stats

Aytu BioPharma Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

Feb 14, 2024

Revenue(YoY)

22.93M

-12.73%
EPS(YoY)

-0.04

+98.14%

Buy

Feb 23, 2024

Aytu BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 21.167M--
--2024/Q3-- / 17.346M--
Feb 14, 20242024/Q222.934M / 21.745M--
Nov 14, 20232024/Q122.099M / 27.726M--
Sep 27, 20232023/Q430.732M / 27.694M--
May 11, 20232023/Q322.733M / 27.550M--
Feb 21, 20232023/Q226.279M / 29.500M--
Nov 14, 20222023/Q127.655M / 24.300M--
Sep 27, 20222022/Q427.448M / 25.500M--
--2022/Q324.199M / 24.500M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 21.167M--
--2024/Q3-- / 17.346M--
Feb 14, 20242024/Q222.934M / 21.745M--
Nov 14, 20232024/Q122.099M / 27.726M--
Sep 27, 20232023/Q430.732M / 27.694M--
May 11, 20232023/Q322.733M / 27.550M--
Feb 21, 20232023/Q226.279M / 29.500M--
Nov 14, 20222023/Q127.655M / 24.300M--
Sep 27, 20222022/Q427.448M / 25.500M--
--2022/Q324.199M / 24.500M--

Unlock Free Earnings Estimates

Aytu BioPharma Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Feb 23, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg